Xmax Inc. annual report, FY2021

Business context and reporting period

The supplied filing is Nova LifeStyle, Inc.’s Form 10-K for the fiscal year ended December 31, 2021—not a filing identified as Xmax Inc. Nova LifeStyle designs and markets furniture, principally through third-party manufacturers, and sells mainly in North America. It also sells therapeutic jade mats in Malaysia. The 2021 results include continuing operations; Bright Swallow was sold in 2020 and is reported as discontinued operations.

Key financial metrics

Metric20212020
Net sales$12.81 million$11.35 million
Gross loss / margin$10.32 million / (81)%$19.89 million / (175)%
Operating expenses$9.48 million$6.41 million
Loss from continuing operations$19.96 million$25.75 million
Net loss$19.96 million$26.08 million
Net loss per share, basic and diluted$3.27$4.54
Cash used in operating activities$4.78 million$2.08 million
Cash and cash equivalents at year-end$6.28 million$8.74 million
Inventory at year-end$17.66 million$32.81 million
Working capital / current ratio$23.75 million / 13.09:1$41.27 million / not stated

Sales rose 13%, reflecting a 29.43% increase in average selling price, partly offset by a 12.78% volume decline. Reported cost of sales included inventory write-downs of $15.96 million in 2021 and $24.01 million in 2020. Excluding those charges, management reported gross profit of $5.64 million and a 44% gross margin in 2021, versus $4.11 million and 36% in 2020; these are non-GAAP-style adjusted figures presented in the filing.

Year-end total liabilities were $6.09 million, including $150,000 of SBA loan principal, $3.31 million of operating lease liabilities, and $1.54 million of income taxes payable. The company reported no credit facilities. Financing cash flow of $2.76 million in 2021 principally reflected net proceeds from an equity offering. The July 2021 offering issued 1,114,508 common shares and warrants; the warrants cover up to 1,225,959 shares in aggregate, including placement-agent warrants.

Material changes versus the prior comparable period

  • Sales increased, but sales volume declined; North America generated 95.9% of continuing-operations sales.
  • Net loss narrowed, largely alongside a smaller inventory write-down. The company nevertheless reported a substantial gross loss and net loss.
  • Selling expenses rose to $3.75 million from $1.75 million, primarily due to advertising and marketing. Advertising expense increased to $2.19 million from $0.28 million.
  • Operating cash outflow more than doubled, and cash and working capital fell. Management attributed operating cash movements in part to inventory purchases, supplier advances, and payment timing.
  • Three suppliers represented 60% of 2021 purchases. No customer represented more than 10% of sales.

Outlook, risks, contingencies, and unusual items

  • Management stated that cash and expected customer receipts should cover working-capital needs and capital expenditures for the next 12 months; the filing gives no specific revenue or earnings guidance. It warns that COVID-19, shipping delays and higher freight costs, weak demand, and supply-chain disruption make 2022 performance difficult to predict.
  • Inventory valuation is a major judgment area: the auditor identified the inventory write-down as a critical audit matter. The filing attributes $15.96 million of 2021 write-downs mainly to slow-moving inventory, including jade mats. Management also describes $39.97 million of write-downs across 2020 and 2021 combined.
  • The Barney securities class action settlement was filed in March 2022 for $750,000, without admission of wrongdoing, and was subject to court approval and other conditions. The filing says insurance is expected to fund the settlement. Two related derivative actions may resume; the company could incur legal costs and advance defense expenses.
  • Nova HK entered liquidation and asset-transfer processes in February 2022; its inventory was transferred to Nova Malaysia on February 15, 2022.
  • The auditor is headquartered in Hong Kong and is included in the PCAOB’s determination of firms it could not fully inspect. The filing warns of potential HFCA Act trading prohibition and Nasdaq delisting risk. The auditor issued an unqualified opinion on the financial statements; management concluded disclosure controls and internal control over financial reporting were effective.
  • Related-party expenses included $399,249 of sales commissions to a consulting firm owned by the CEO and $300,000 of technology-service fees to a firm whose sole shareholder was a director of Nova Macao.

Important facts for investors to verify

  1. Confirm the registrant identity: the supplied document is Nova LifeStyle, Inc. (Nasdaq: NVFY), not Xmax Inc.
  2. Review inventory aging, the basis for the write-downs and remaining inventory recoverability; reconcile the $15.96 million 2021 charge with the $39.97 million cumulative amount described in the risk factors.
  3. Assess cash burn, liquidity needs, supplier prepayments, and the sustainability of management’s 12-month liquidity assertion, particularly given the lack of credit facilities.
  4. Check court approval and insurance coverage for the $750,000 class-action settlement, and monitor the status and potential cost of the derivative actions.
  5. Evaluate PCAOB inspection and HFCA Act developments, Nasdaq listing compliance, and potential dilution from outstanding warrants and equity-plan authorizations.
  6. Review the terms, approval process, and ongoing amounts of the disclosed related-party arrangements.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.